Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SweatStop is a topical antiperspirant product line developed by Blaine Labs for the treatment of hyperhidrosis and excessive sweating. Unlike traditional antiperspirants that rely on aluminum salts to block sweat ducts, SweatStop formulations use tannic acid (3%) as a plant-based astringent. Tannic acid works by precipitating skin proteins, which acts as a natural drying agent to reduce moisture at the source. The product line includes the SweatStop Astringent Spray and SweatStop Moisture-Reducing Body Spray, which are marketed as aluminum-free, paraben-free, and aerosol-free. These products are designed for application to the hands, feet, underarms, and other body parts affected by excessive perspiration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SweatStop (Blaine Labs).